Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca    AZN   GB0009895292

ASTRAZENECA

(AZN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201620172018201920202021
Sales23 00222 46522 09023 51225 96328 478
EBITDA9 0789 8919 4258 0259 32210 657
Operating profit (EBIT)6 7216 8555 6726 3317 4728 858
Pre-Tax Profit (EBT)3 4062 2271 9933 5954 8736 384
Net income3 4993 0012 1553 0254 1195 568
P/E ratio19,829,244,035,826,119,1
EPS ( $ )2,772,371,702,142,934,00
Dividend per Share ( $ )2,802,802,802,792,762,93
Yield5,11%4,05%3,74%3,65%3,61%3,82%
Reference price ( $ )54.869.174.976.52276.52276.522
Announcement Date02/02/2017
08:11am
02/02/2018
07:00am
02/14/2019
07:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201620172018201920202021
Debt11 79014 48313 00311 99412 22011 180
Finance------
Operating income (EBITDA)9 0789 8919 4258 0259 32210 657
Leverage
(Debt/EBITDA)
1,30x1,46x1,38x1,49x1,31x1,05x
Capital Expenditure1 4461 3261 0431 3411 3671 357
Book Value Per Share (BVPS)11,7 $--11,6 $11,0 $12,3 $
Cash Flow per Share3,27 $2,82 $2,07 $4,50 $5,14 $6,20 $
Announcement Date02/02/2017
08:11am
02/02/2018
07:00am
02/14/2019
07:00am
---
Balance Sheet Analysis
Assessed data source :
© 2019 Thomson Reuters
Financial Ratios

Size 2019e 2020e
Capitalization 100 727 M$ -
Entreprise Value (EV) 112 721 M$ 112 948 M$
Valuation 2019e 2020e
P/E ratio (Price / EPS) 35,8x 26,1x
Capitalization / Revenue 4,28x 3,88x
EV / Revenue 4,79x 4,35x
EV / EBITDA 14,0x 12,1x
Yield (DPS / Price) 3,65% 3,61%
Price to book (Price / BVPS) 6,58x 6,95x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 26,9% 28,8%
operating Leverage (Delta EBIT / Delta Sales) 1,80x 1,73x
Net Margin (Net Profit / Revenue) 12,9% 15,9%
ROA (Net Profit / Asset) 5,72% 7,65%
ROE (Net Profit / Equities) 28,4% 36,2%
Rate of Dividend 131% 94,1%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   5,70% 5,26%
Cash Flow / Sales 25,1% 25,9%
Capital Intensity (Assets / Sales) 2,25x 2,07x
Financial Leverage (Net Debt / EBITDA) 1,49x 1,31x
EPS & Dividend